HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

UMich Study Links Triclosan To Bacterial Colonization, Infection Risks

This article was originally published in The Rose Sheet

Executive Summary

Researchers have identified a positive correlation between triclosan’s presence in adult nasal secretions and colonization of Staphylococcus aureus, a risk factor for potentially deadly infections, the investigators say. Their findings “suggest that a reevaluation of triclosan in consumer products is urgently needed,” according to the study.

You may also be interested in...



Antibacterial Soaps Reduce Risk Of Foodborne Illness – Industry Study

A study funded in part by the Personal Care Products Council found use of antibacterial treatments to reduce concentrations of Shigella bacteria on participants’ hands significantly, leading to reduced levels transferred to melon balls and compelling estimates of reduced illness in eaters. FDA has requested such data as it considers GRASE conditions for antibacterial washes under a proposed rule issued in December 2013 that could require manufacturers to reformulate and relabel products.

FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling

FDA proposes to amend the OTC antiseptic drug product monograph to require more detailed safety and efficacy tests, pointing to mounting data that shows antibacterial wash products could pose health risks and contribute to increase antibacterial resistance.

‘Astonishing Results’ Or ‘Outrageous’ Claims? Peter Thomas Roth Fighting Bicoastal Class Actions

Plaintiffs against the prestige, “clinical” skin-care company are targeting anti-aging claims on its Rose Stem Cell Bio-Repair line and statements about hyaluronic acid’s ultra-moisturizing capabilities, used to market its Water Drench range. PTR faces false advertising class actions in California and New York federal courts, and the former case appears to be headed for trial.

UsernamePublicRestriction

Register

RS019004

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel